🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tao Ji

Cytori Therapeutics (United States)

ORCID: 0000-0003-4522-8888
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.

200 citations

Nicholas Iannotti, Martin Gutierrez, David C. Smith, Luis Féliz, Christine Lihou +5 more

8 citations

Xie-Jun Zhang, Tao Ji, Guo-Dong Huang, Wen-Jian Zheng